These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31937582)

  • 1. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes.
    Vu L; An J; Kovalik T; Gendron T; Petrucelli L; Bowser R
    J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):350-358. PubMed ID: 31937582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
    Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
    J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
    Gray E; Thompson AG; Wuu J; Pelt J; Talbot K; Benatar M; Turner MR
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1296-1306. PubMed ID: 32666680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase.
    Oeckl P; Weydt P; Steinacker P; Anderl-Straub S; Nordin F; Volk AE; Diehl-Schmid J; Andersen PM; Kornhuber J; Danek A; Fassbender K; Fliessbach K; ; Jahn H; Lauer M; Müller K; Knehr A; Prudlo J; Schneider A; Thal DR; Yilmazer-Hanke D; Weishaupt JH; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):4-10. PubMed ID: 30224549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
    Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
    BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression.
    Andrés-Benito P; Domínguez R; Colomina MJ; Llorens F; Povedano M; Ferrer I
    Aging (Albany NY); 2018 Sep; 10(9):2367-2382. PubMed ID: 30215603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.
    Steinacker P; Verde F; Fang L; Feneberg E; Oeckl P; Roeber S; Anderl-Straub S; Danek A; Diehl-Schmid J; Fassbender K; Fliessbach K; Foerstl H; Giese A; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer GB; Lauer M; Pinkhardt EH; Prudlo J; Rosenbohm A; Schneider A; Schroeter ML; Tumani H; von Arnim CAF; Weishaupt J; Weydt P; Ludolph AC; Yilmazer Hanke D; Otto M;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):239-247. PubMed ID: 29142138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of CHI3L1+ Astrocytes in Progression in MS.
    Cubas-Núñez L; Gil-Perotín S; Castillo-Villalba J; López V; Solís Tarazona L; Gasqué-Rubio R; Carratalá-Boscá S; Alcalá-Vicente C; Pérez-Miralles F; Lassmann H; Casanova B
    Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33658322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.
    Schneider R; Bellenberg B; Gisevius B; Hirschberg S; Sankowski R; Prinz M; Gold R; Lukas C; Haghikia A
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33172960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study.
    Pagliardini V; Pagliardini S; Corrado L; Lucenti A; Panigati L; Bersano E; Servo S; Cantello R; D'Alfonso S; Mazzini L
    J Neurol Sci; 2015 Jan; 348(1-2):245-50. PubMed ID: 25563799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS.
    Rosén C; Mitre B; Nellgård B; Axelsson M; Constantinescu R; Andersen PM; Dalla K; Blennow K; Nilsson G; Zetterberg H; Rosén H
    J Neurol Sci; 2024 Aug; 463():123112. PubMed ID: 38972199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Benninger F; Glat MJ; Offen D; Steiner I
    J Clin Neurosci; 2016 Apr; 26():75-8. PubMed ID: 26602604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
    De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
    Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
    Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
    Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.